Verruca Vulgaris — Trials

Verruca Vulgaris — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07806617	Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts	active not recruiting	Phase 2	55	Rush University Medical CenterOTHER	1	Sep 15, 2026	clinicaltrials
NCT05799157	Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts	completed	Phase 2	153	Veradermics, Inc.INDUSTRY	1	May 8, 2025	clinicaltrials
NCT03487549	Cantharidin and Occlusion in Verruca Epithelium(COVE-1)	completed	Phase 2	56	Verrica Pharmaceuticals Inc.INDUSTRY	1	Nov 27, 2024	clinicaltrials
NCT05896215	OM202JP Clinical Study of KNP2002

Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials